Portfolio company
EyeYon
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops synthetic corneal implants and therapeutic contact lenses for patients with corneal diseases, providing alternatives to traditional donor tissue transplants.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
StemSight
This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.
INEYE Therapeutics
This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.
VisusNano
This company develops drug-eluting intraocular lens implants for patients undergoing cataract surgery to eliminate the need for post-operative eye drops.
Pixium Vision
This company develops bionic vision restoration systems and retinal implants for patients who have lost their sight due to degenerative eye diseases.
Cornea Project
This company develops point-of-care diagnostic devices and molecular biomarker analysis technologies for ophthalmologists to detect corneal diseases like keratoconus and dry eye syndrome.
Trefoil Therapeutics
The company develops engineered protein therapies to treat corneal endothelial and epithelial diseases for patients with vision loss or ocular surface damage.
Eyexora
This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.
Glakolens
This company develops sensor-embedded contact lenses that provide continuous intraocular pressure monitoring for patients with glaucoma and ocular hypertension.
